Pietro Lo Riso
Impact in
-
- Virus-based gene therapy research
- Animal Genetics and Reproduction
Papers in
-
- Pluripotent Stem Cells Research 2
- CRISPR and Genetic Engineering 2
- Epigenetics and DNA Methylation 1
- Oncology 3
- Cancer Cells and Metastasis 2
- PARP inhibition in cancer therapy 1
- Co-authors
- Vania Broccoli (2 shared papers)Luigi Naldini (1 shared paper)Daniela Cesana (1 shared paper)Margherita Neri (1 shared paper)Pietro Genovese (1 shared paper)Bruno Di Stefano (1 shared paper)Daniele Colombo (1 shared paper)Alessio Cantore (1 shared paper)
- Journals
- Nature Methods (1 paper)Journal of Clinical Oncology (1 paper)Cell Reports (1 paper)Stem Cell Reports (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Pietro Lo Riso
8 papers receiving 394 citations
Peers
Comparison fields: 5 of 49
- Genetics 155
- Business and International Management 10
- Molecular Biology 307
- Developmental Neuroscience 16
- Oncology 77
Countries citing papers authored by Pietro Lo Riso
This map shows the geographic impact of Pietro Lo Riso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Lo Riso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Lo Riso more than expected).
Fields of papers citing papers by Pietro Lo Riso
This network shows the impact of papers produced by Pietro Lo Riso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Lo Riso. The network helps show where Pietro Lo Riso may publish in the future.
Co-authors
The 25 scholars most cited alongside Pietro Lo Riso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 248 | |
| 2 | 2019 | 37 | |
| 3 | 2018 | 33 | |
| 4 | 2021 | 32 | |
| 5 | 2018 | 28 | |
| 6 | 2022 | 11 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 1 | |
| 9 | 2019 | 0 |
About Pietro Lo Riso
Pietro Lo Riso is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Reproductive Medicine, having authored 9 papers that have together received 398 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Pluripotent Stem Cells Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer Cells and Metastasis (2 papers), CRISPR and Genetic Engineering (2 papers), PARP inhibition in cancer therapy (1 paper), Genetics and Neurodevelopmental Disorders (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Genetics (155 citations), Business and International Management (10 citations), Molecular Biology (307 citations), Developmental Neuroscience (16 citations) and Oncology (77 citations). Pietro Lo Riso has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Vania Broccoli, Luigi Naldini, Daniela Cesana, Margherita Neri, Pietro Genovese, Bruno Di Stefano, Daniele Colombo, Alessio Cantore, Angelo Lombardo and Zulma Magnani. Their work appears in journals such as Nature Methods, Journal of Clinical Oncology, Cell Reports, Stem Cell Reports and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.